Webcasts

Insider State of the Industry: Ukraine, supply chains, and CDMO gains

Another quarter, another industry snapshot. We sat down with experts at BPI West to discuss the current state of biomanufacturing. Our State of the Industry series began last year to allow reflection on quarterly trends within the bioprocess and manufacturing sector. Clearly the pandemic has driven much of the conversation, but in a sign of COVID’s decline this quarter’s panel was held not on Zoom, Teams, or Skype but in a real face-to-face setting: BPI West in San Diego. Our…

BioProcess Insider State of the Industry – Live from BPI West, March 2022

BioProcess Insider’s State of the Industry takes a deeper look into the recent business news affecting the biomanufacturing industry, picking apart the numbers and highlighting potential trends. With a panel of industry experts, editor Dan Stanton discusses recent mergers and acquisitions in the bioprocess space, bottlenecks within the manufacturing sector, the continued head- and tailwinds COVID-19 is placing on businesses, and the evolution of the cell and gene therapy landscape and what that means for supply chains. Panelists: Frank Orlowski,…

BioProcess Insider State of the Industry — December 2021 Panel Discussion

This webcast features: Georgia Sloboda, Managing Director, Latham BioPharm Group; John Hamer, Head of Sales & Marketing, Aseptic Filling Workcells, Cytiva; and James Taylor, PhD, Co-Founder & General Manager, Precision Nano Systems Inc. BioProcess Insider’s State of the Industry takes a deeper look into the recent business news affecting the biomanufacturing industry, picking apart the numbers and highlighting potential trends. With a panel of industry experts, editor Dan Stanton will discuss recent M&A in the bioprocess space, bottlenecks within the…

BioProcess Insider State of the Industry — September 2021 Panel Discussion

Our BioProcess Insider editorial team sits down with Joshua Speidel, PhD Partner, Latham Biopharm Group, Patrick Lucy, President and CEO, Lykan Biosciences, and Amélie Boulais, Head of Market Entry Strategy, Virus Based Therapeutics at Sartorius, to reflect on how the quarterly movements of the wider pharma industry are affecting the biomanufacturing space. Through the analysis of global events, recent deal making, and regulatory and technological advancements, we look to determine the factors driving or squeezing production and pre-empt upcoming trends…